A detailed history of Chevy Chase Trust Holdings, Inc. transactions in Novo Nordisk A S stock. As of the latest transaction made, Chevy Chase Trust Holdings, Inc. holds 3,791 shares of NVO stock, worth $399,268. This represents 0.0% of its overall portfolio holdings.

Number of Shares
3,791
Previous 3,871 2.07%
Holding current value
$399,268
Previous $552,000 18.3%
% of portfolio
0.0%
Previous 0.0%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$119.07 - $145.42 $9,525 - $11,633
-80 Reduced 2.07%
3,791 $451,000
Q2 2024

Jul 22, 2024

BUY
$122.71 - $146.91 $475,010 - $568,688
3,871 New
3,871 $552,000
Q1 2020

May 13, 2020

SELL
$49.46 - $64.78 $53,861 - $70,545
-1,089 Closed
0 $0
Q4 2019

Feb 12, 2020

BUY
$49.86 - $58.26 $54,297 - $63,445
1,089 New
1,089 $63,000

Others Institutions Holding NVO

About NOVO NORDISK A S


  • Ticker NVO
  • Exchange OTC
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 2,257,289,984
  • Market Cap $238B
  • Description
  • Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...
More about NVO
Track This Portfolio

Track Chevy Chase Trust Holdings, Inc. Portfolio

Follow Chevy Chase Trust Holdings, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Chevy Chase Trust Holdings, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Chevy Chase Trust Holdings, Inc. with notifications on news.